Future studies need to explore strategies (such as modulation of YAP, LATS1/2, and MST1/2 expression) that will help make clinical diagnosis more accurate, more sensitive, and faster to allow assessment of the progress and improve the treatment and prognosis of kidney diseases. Here, LATS1 is linked to kidney disorder.